Skip to main content

Table 4 Annual percentage change from baseline in tibial cartilage volume over 24 months

From: Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial

 

MPC + HA

HA alone

p*

Medial tibia

 6 months

0.7 (5.9)

–4.0 (3.9)

0.10

 12 months

0.3 (6.3)

–2.4 (3.1)

0.36

 24 months

–1.4 (4.2)

–3.3 (5.3)

0.54

Lateral tibia

 6 months

–1.4 (5.3)

–2.7 (4.4)

0.65

 12 months

–4.7 (3.4)

–2.6 (2.5)

0.25

 24 months

–3.7 (3.4)

–0.8 (3.5)

0.22

  1. Data are reported as mean (SD)
  2. * For difference between two groups using independent samples t test
  3. HA hyaluronan, MPC mesenchymal precursor cell
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us